化学原料药
(C060201.国证.三级)A股通融
(
市盈率
46.69
市净率
2.87
股息率
1.01%
)·市值加权
发布时间2011-01-04样本数47市值3,698.70亿元A股市值3,665.88亿元流通市值3,000.47亿元自由流通市值2,017.52亿元陆股通持仓金额占市值比例0.99% (30.91亿元2025-06-30) 融资融券余额占市值比例2.87% (融资余额104.44亿元融券余额2,526.39万元2025-08-07) 行业估值数据计算说明文档行业财务数据计算说明文档
二级:制药 (C0602)
(
市盈率
40.32
市净率
2.88
股息率
1.43%
)·市值加权
一级:医药卫生 (C06)
(
市盈率
51.21
市净率
3.26
股息率
1.22%
)·市值加权
关注
279
发表讨论

化学原料药(C060201).国证 - 样本列表

最后更新于：2025-08-08

# 公司名称 市值市盈率市净率股息率涨跌幅今年以来投资收益率公司性质财报日期公告时间营业总收入归属于母公司普通股股东的净利润归属于母公司普通股股东的加权ROE
累积同比累积同比累积同比
1博瑞医药 通
688166.sh		485.46亿元351.6420.350.08%6.82%280.86%自然人2025-q12025-04-182.49亿元-26.81%1,295.98万元-79.77%0.53%-2.14%
关注
237
2川宁生物 通
301301.sz		272.07亿元20.373.582.21%-1.21%5.02%自然人2025-q12025-04-2912.97亿元-14.85%2.88亿元-18.26%3.58%-1.36%
关注
94
3普洛药业 通
000739.sz		181.76亿元17.552.762.27%0.13%-1.02%集体2025-q12025-04-1827.30亿元-14.63%2.49亿元1.98%4.00%0.16%
关注
923
4九洲药业 通
603456.sh		161.61亿元24.601.862.74%0.66%35.59%自然人2025-q22025-08-0628.71亿元3.86%5.26亿元10.70%6.02%0.48%
关注
602
5浙江医药 通
600216.sh		149.53亿元10.241.402.36%0.58%0.44%自然人2025-q12025-04-2422.55亿元0.28%4.09亿元273.08%3.77%2.64%
关注
529
6新ST诺泰
688076.sh		146.90亿元29.945.691.37%2.29%27.13%自然人2025-q12025-04-235.66亿元58.96%1.53亿元130.10%5.57%2.57%
关注
148
7东诚药业 通
002675.sz		141.75亿元98.283.170.47%-1.04%40.97%自然人2025-q12025-04-306.87亿元6.13%2,473.15万元-61.55%0.55%-0.79%
关注
414
8国邦医药 通
605507.sh		128.98亿元15.491.602.60%-0.86%14.06%自然人2025-q22025-07-3030.26亿元4.63%4.56亿元12.60%5.61%0.27%
关注
84
9新华制药 通
000756.sz		116.09亿元26.372.331.63%2.62%8.69%国有2025-q12025-04-2924.30亿元-1.81%1.12亿元-20.99%2.21%-0.83%
关注
305
10皓元医药 通
688131.sh		111.67亿元45.173.940.36%-0.09%48.03%自然人2025-q12025-04-306.06亿元20.05%6,238.44万元272.28%2.14%1.48%
关注
149
11海翔药业 通
002099.sz		97.77亿元-27.651.900%-0.33%17.05%自然人2025-q12025-04-294.86亿元-7.95%922.99万元-71.68%0.18%-0.40%
关注
306
12奥锐特 通
605116.sh		94.97亿元24.234.121.24%2.54%12.27%自然人2025-q12025-04-264.02亿元19.78%1.19亿元45.30%4.97%1.83%
关注
158
13天宇股份 通
300702.sz		90.47亿元89.052.540.19%3.17%56.38%自然人2025-q12025-04-257.59亿元10.13%8,618.35万元112.71%2.43%1.28%
关注
412
14奥翔药业 通
603229.sh		88.43亿元41.423.860.94%2.11%7.75%自然人2025-q12025-04-303.07亿元1.90%1.19亿元5.97%5.11%-0.01%
关注
226
15花园生物 通
300401.sz		85.27亿元27.142.820.73%-0.06%7.84%自然人2025-q12025-04-183.26亿元-1.18%9,651.14万元5.50%2.95%-0.16%
关注
545
16尔康制药 通
300267.sz		82.71亿元-23.761.850%0%44.24%自然人2025-q12025-04-233.54亿元28.19%2,811.26万元868.91%0.63%0.57%
关注
252
17兄弟科技
002562.sz		63.82亿元73.422.040%0.67%41.18%自然人2025-q12025-04-269.19亿元12.10%2,090.81万元182.95%0.67%1.50%
关注
296
18宏源药业 通
301246.sz		62.64亿元214.881.440.19%-0.32%15.97%自然人2025-q12025-04-254.33亿元1.73%888.61万元-71.52%0.21%-0.50%
关注
24
19昊帆生物 通
301393.sz		60.83亿元43.752.670.69%-0.02%41.82%自然人2025-q12025-04-281.35亿元48.21%3,479.90万元16.66%1.52%0.18%
关注
38
20新天地
301277.sz		60.07亿元34.474.041.86%-0.39%58.84%自然人2025-q12025-04-222.20亿元19.07%5,657.12万元1.17%3.60%-0.19%
关注
40
21永安药业
002365.sz		58.05亿元202.142.980.50%-1.60%147.43%自然人2025-q12025-04-291.71亿元-12.96%-436.72万元-115.23%-0.22%-1.66%
关注
222
22美诺华
603538.sh		57.31亿元77.462.670.19%10.00%105.63%自然人2025-q12025-04-302.76亿元5.22%2,122.17万元51.12%0.96%0.29%
关注
323
23富祥药业 通
300497.sz		56.93亿元-20.982.610%1.87%24.10%自然人2025-q12025-04-262.34亿元-31.35%223.88万元52.46%0.10%0.05%
关注
4710
24键凯科技
688356.sh		56.75亿元208.144.470.16%0.18%64.67%自然人2025-q12025-04-296,910.41万元6.66%1,188.05万元-17.79%0.93%-0.20%
关注
190
25亨迪药业 通
301211.sz		53.77亿元129.262.381.34%-0.32%-10.99%自然人2025-q22025-08-012.35亿元-2.93%1,854.71万元-72.92%0.80%-2.15%
关注
50
26森萱医药
830946.bj		51.66亿元43.804.451.16%-1.71%38.91%2025-q12025-04-291.26亿元-8.80%2,903.25万元-16.72%2.41%-0.61%
关注
40
27向日葵
300111.sz		50.84亿元711.587.410%3.95%21.91%自然人2025-q12025-04-267,223.12万元-13.69%-13.09万元-123.77%-0.02%-0.14%
关注
127
28津药药业 通
600488.sh		49.68亿元37.221.652.15%1.79%9.76%2025-q12025-04-297.86亿元-9.03%5,805.01万元0.07%1.88%-0.06%
关注
133
29司太立
603520.sh		47.96亿元-101.971.851.37%-0.09%27.09%自然人2025-q12025-04-306.86亿元6.79%1,434.43万元16.79%0.54%-0.16%
关注
394
30拓新药业
301089.sz		43.44亿元-170.242.800%-3.43%21.78%自然人2025-q12025-04-269,699.47万元-10.46%-356.47万元-272.34%-0.23%-0.36%
关注
91
31北大医药
000788.sz		40.59亿元29.082.631.17%0%13.97%自然人2025-q12025-04-255.02亿元1.70%4,564.06万元3.62%2.97%-0.08%
关注
164
32科源制药
301281.sz		38.69亿元62.412.840.56%-1.33%20.20%自然人2025-q12025-04-251.11亿元-23.98%2,308.49万元7.21%1.68%0.08%
关注
20
33海森药业
001367.sz		37.84亿元31.442.780.46%0.77%36.11%自然人2025-q12025-04-261.18亿元2.32%3,121.22万元-6.51%2.29%-0.35%
关注
35
34同和药业
300636.sz		35.36亿元42.191.530.48%0.24%6.21%自然人2025-q12025-04-251.87亿元-9.47%2,078.14万元-52.30%0.90%-1.04%
关注
159
35圣达生物
603079.sh		34.59亿元73.102.230%-1.13%35.86%自然人2025-q12025-04-282.03亿元9.95%2,170.95万元469.35%1.71%1.40%
关注
259
36富士莱
301258.sz		34.52亿元99.901.820.24%3.66%59.91%自然人2025-q12025-04-221.13亿元17.44%2,393.68万元313.65%1.26%0.96%
关注
59
37赛托生物
300583.sz		34.49亿元-28.901.910.06%-0.66%-6.95%自然人2025-q12025-04-292.60亿元6.32%-2,750.85万元-995.83%-1.51%-1.66%
关注
81
38山河药辅
300452.sz		33.15亿元28.393.912.11%-1.39%19.73%自然人2025-q12025-04-232.48亿元4.28%4,717.69万元-5.30%5.08%-0.52%
关注
406
39河化股份
000953.sz		30.79亿元37.6520.970%3.83%50.45%自然人2025-q12025-04-294,083.31万元-34.05%136.20万元217.42%0.93%2.67%
关注
98
40共同药业
300966.sz		27.41亿元-91.213.320%-3.96%47.43%自然人2025-q12025-04-291.39亿元13.90%108.21万元-69.50%0.12%-0.25%
关注
64
41东亚药业
605177.sh		24.61亿元-18.701.400%2.63%8.88%自然人2025-q12025-04-301.91亿元-45.85%-691.96万元-128.78%-0.37%-1.56%
关注
76
42广济药业
000952.sz		24.55亿元-8.742.390%2.76%14.56%国有2025-q12025-04-281.48亿元-17.58%-3,626.62万元28.20%-3.46%0.31%
关注
190
43无锡晶海
836547.bj		20.19亿元42.683.030.77%-1.18%67.35%自然人2025-q12025-04-291.04亿元13.04%1,913.27万元30.39%2.85%0.41%
关注
12
44海昇药业
870656.bj		18.61亿元39.392.881.07%-1.06%50.66%自然人2025-q12025-04-254,198.28万元0.17%1,326.09万元-20.91%2.01%-1.15%
关注
14
45新赣江
873167.bj		18.50亿元130.753.920.96%-2.25%86.28%自然人2025-q12025-04-283,413.77万元-14.34%532.25万元-60.82%1.12%-1.73%
关注
14
46峆一药业
430478.bj		18.16亿元32.173.771.24%-0.04%95.30%自然人2025-q12025-04-288,034.16万元14.73%1,923.13万元54.39%3.89%1.19%
关注
19
47欧康医药
833230.bj		17.44亿元112.794.350.44%0.06%62.17%自然人2025-q12025-04-285,837.29万元-14.46%167.26万元-80.67%0.41%-1.77%
关注
13

©2016-2024 理杏仁 | 北京乾谦慧科技有限公司 | 违法和不良信息举报中心 互联网违法和不良信息投诉：010-86460785

推荐Chrome浏览器 | 京公网安 京公网安备11010502033936号 | 京B2-20201471 | 京ICP备16057978号 | 用户协议

风险提示: 本站所有免费及收费信息和数据仅供参考，不构成投资建议，理杏仁不承担由此导致的任何法律责任。